Gvanabenz

Gvanabenz
(IUPAC) ime
	2-(2,6-dihlorobenziliden)hidrazinkarboksimidamid
Klinički podaci
AHFS/Drugs.com	Potrošačka informacije o leku
MedlinePlus	a686003
Identifikatori
CAS broj	5051-62-7
ATC kod	nije dodeljen
PubChem	5702063
DrugBank	DB00629
ChemSpider	4642445
UNII	GGD30112WC
KEGG	D04375
ChEMBL	CHEMBL420
Hemijski podaci
Formula	C8H8Cl2N4
Mol. masa	231,081 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+ ; Key: WDZVGELJXXEGPV-YIXHJXPBSA-N
Farmakokinetički podaci
Vezivanje za proteine plazme	90%
Poluvreme eliminacije	6 sata
Farmakoinformacioni podaci
Trudnoća	C(US)
Pravni status

Guanabenz (Wytensin) je alfa agonist alfa-2 tipa koji se koristi kao antihipertenzivni lek. On se upotrebljava za tretiranje visokog krvnog pritiska (hipertenzije).^[6]^[7]

Najčešće nuspojava tomo njegove upotrebe su nesvestica, pospanost, suva usta, glavobolja i slabost.

Reference[uredi | uredi kod]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Walker BR, Hare LE, Deitch MW (1982). „Comparative antihypertensive effects of guanabenz and clonidine”. The Journal of International Medical Research 10: 6-14. PMID 7037502.
↑ Bonham AC, Trapani AJ, Portis LR, Brody MJ (1984). „Studies on the mechanism of the central antihypertensive effect of guanabenz and clonidine”. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension 2: S543-6.

Spoljašnje veze[uredi | uredi kod]

	Portal Medicina
	Portal Hemija

Molimo Vas, obratite pažnju na važno upozorenje u vezi tema o zdravlju (medicini).

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Walker BR, Hare LE, Deitch MW (1982). „Comparative antihypertensive effects of guanabenz and clonidine”. The Journal of International Medical Research 10: 6-14. PMID 7037502.

[7] Bonham AC, Trapani AJ, Portis LR, Brody MJ (1984). „Studies on the mechanism of the central antihypertensive effect of guanabenz and clonidine”. Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension 2: S543-6.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Gvanabenz

Reference[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]

Navigacija